The European point of care ultrasound (PoCUS) device market is projected to grow significantly, moving from an estimated USD 310.43 million in 2025 to approximately USD 593.20 million by 2035, reflecting a compound annual growth rate (CAGR) of 6.69%.
This growth is primarily fueled by an increasing demand for immediate diagnostics at the bedside, the rising reliance on portable imaging technologies, and the integration of ultrasound-guided procedures across various healthcare settings. The region's healthcare modernization initiatives, bolstered by European Commission policies, are accelerating the adoption of decentralized imaging technologies, which aim to enhance workflow efficiency and patient outcomes.
Key drivers of this market expansion include the rising prevalence of chronic diseases necessitating quick imaging diagnostics, a growing preference for portable ultrasound systems, and public investments aimed at modernizing diagnostic infrastructures. However, challenges such as stringent regulatory processes, budget constraints in smaller healthcare facilities, and the need for trained personnel for accurate image interpretation could hinder wider adoption.
Looking ahead, the future of the PoCUS market in Europe seems promising, with a strong emphasis on scalable, AI-assisted handheld systems and cloud-based consultation capabilities. Investment opportunities are particularly ripe for affordable imaging solutions and clinician training programs, suggesting that companies that can effectively merge cost-efficiency with advanced diagnostic capabilities will likely thrive in this evolving landscape.